Completed PHASE2 INTERVENTIONAL 3-arm NCT00007267

Psychological Treatments for Scleroderma

Psychosocial Interventions for Scleroderma

Sponsor: Johns Hopkins University

Conditions Depression Pain Scleroderma Systemic Sclerosis

Interventions Cognitive behavioral therapy Disease/health education Self-help cognitive behavioral intervention facilitated by a psychologist

Updated 6 times since 2017 Last updated: Aug 8, 2017 Started: Jun 30, 2001 Primary completion: Jun 30, 2006 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Depression and Pain, this trial is completed. The trial is conducted by Johns Hopkins University and has accumulated 6 data snapshots since 2001. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Aug 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Completed PHASE2

First recorded

Jun 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States